Actinium Pharmaceuticals (ATNM) Net Equity Issued and Repurchased (2012 - 2024)
Actinium Pharmaceuticals (ATNM) reported Net Equity Issued and Repurchased of -$1,000 for Q4 2024, compared with -$12.21 million a year earlier.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Net Equity Issued and Repurchased (2012 - 2024) Analysis & Trends
For FY2024, Actinium Pharmaceuticals posted Net Equity Issued and Repurchased of $29.33 million, up 97.2% from FY2023.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 11.0% (FY2019 to FY2024).
- By year, Net Equity Issued and Repurchased came in at $14.87 million in FY2023 (-35.8%), $23.16 million in FY2022, $6,000 in FY2021 (-100.0%) and $76.64 million in FY2020 (+339.5%).
- Five-year quarterly Net Equity Issued and Repurchased spans a low of -$12.21 million in Q4 2023 and a high of $52.17 million in Q2 2020.
- Per Business Quant data, the three quarters before Q4 2024 came in at $4.6 million (Q3 2024), $9.96 million (Q2 2024) and $14.77 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Actinium Pharmaceuticals | 49.05 Mn | -130.95 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 4.60 Mn |
| Jun 30, 2024 | 9.96 Mn |
| Mar 31, 2024 | 14.77 Mn |
| Dec 31, 2023 | -12.21 Mn |
| Sep 30, 2023 | 5.66 Mn |
| Jun 30, 2023 | 20.65 Mn |
| Mar 31, 2023 | 771,000.00 |
| Dec 31, 2022 | 4.89 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2021 | -14.36 Mn |
| Mar 31, 2021 | 14.36 Mn |
| Dec 31, 2020 | 21.89 Mn |
| Sep 30, 2020 | -94,000.00 |
| Jun 30, 2020 | 52.17 Mn |
| Mar 31, 2020 | 2.67 Mn |
| Sep 30, 2019 | 444,000.00 |
| Jun 30, 2019 | 16.61 Mn |
| Mar 31, 2019 | 380,000.00 |
| Dec 31, 2018 | 3.17 Mn |
API Access
Actinium Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();